Wave Life Sciences

📍 Cambridge, United States👥 303 employees💰 Last funded Sep 2019
Biotechnology Research🌐 wavelifesciences.com
Website LinkedIn
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. We aspire to develop best-in-class medicines across multiple therapeutic modalities using PRISM™, our proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, we are targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Japan
1
Investor activity2012–2019 · investors recorded per year
201212016120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Wave Life Sciences?
Wave Life Sciences has 4 investors on record on gritt.io.
When did Wave Life Sciences last raise funding?
The most recent investment in Wave Life Sciences recorded on gritt.io was in September 2019.
What industry is Wave Life Sciences in?
Wave Life Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Wave Life Sciences based?
Wave Life Sciences is headquartered in Cambridge, United States.